Gene therapies for Ocular diseases

DR. NIKOLAOS PAPAZOGLOU MD

CEO and Co-Founder

Niko is a surgeon ophthalmologist with over 20 years of clinical experience in the public and private sector as well as in the Air Force.

He served as scientific director of one of the largest private eye clinics in Eastern Europe, with special interest in cataract, glaucoma, refractive surgery, pediatric ophthalmology and ocular genetics.

He is also an experienced computer programmer who has developed software for diagnostic purposes in Ophthalmology, as well as innovative programs in other disciplines, such as organic chemistry, satellite navigation, multimedia applications, music technology and image processing applications.

ELIZABETH PARRISH MBA

COO and Co-Founder

Liz is one of the most prominent figures in the global longevity community and has dedicated her life to the fight against aging.

A humanitarian, entrepreneur, innovator, author and a public speaker for genetic cures, she is the first human to receive gene therapies to treat aging.

She is the founder and CEO of BioViva Sciences USA Inc. which is committed to extending healthy lifespans using gene therapy, and co-founder, Chief Operating Officer and Chief Marketing Officer of GENORASIS™.

Dr. Bill Andrews is the Founder and CEO of Sierra Sciences, a company focused on finding ways to extend human lifespan and health span. Bill has been featured in Popular Science, The Today Show, The Doctor’s TV Show, and numerous documentaries on the topic of life extension. Bill co-stars with Dr. Aubrey de Grey in the documentary “The Immortalists” that almost won an Oscar in 2014 and will be featured in the upcoming documentary called “Longevity Hackers” to be released in 2023.
He received his Ph.D. in Molecular & Population Genetics in 1981 from the University of Georgia.
Bill worked as a medical researcher in various corporations, focusing on cancer, heart disease, inflammation, and aging. Bill played key roles in the discoveries of Human Growth Hormone, Tissue Plasminogen Activator, Osteo-Inductive Factor, Erythropoietin, Beta-Seron, Telomerase, and Imetelstat, to name a few. In 1997 Bill was awarded 2nd Place as National Inventor of the Year for his cancer research. In the early-to-mid 1990s, while at Geron Corporation, Bill led the research to discover both the RNA and protein components of human telomerase, the enzyme responsible for preventing telomeres from shortening in our reproductive cells.

Mike joined Midwestern University after working in drug discovery and development for over 20 years. He brings five years of experience as a biotechnology consultant at two major pharmaceutical and biotechnology companies, where he held positions ranging from research scientist to chief executive officer (CEO).
He received his Bachelor of Science degree in Biology from the California Institute of Technology, his Doctor of Philosophy (Ph.D.) in Neuroscience from the University of California at Irvine, and his Doctor of Optometry (O.D.) degree from the New England College of Optometry.
He discovered or co-discovered 10 clinical candidates and is the inventor or co-inventor on a number of U.S. patents.

Aubrey is a world-famous gerontologist and biomedical researcher, known for his groundbreaking work in the field of regenerative medicine and aging. He earned his bachelor's degree in Computer Science and his Ph.D. in Biology from the University of Cambridge. His pioneering research has been widely recognized, and he has received numerous international awards and honors.
In addition to his scientific work, Aubrey is a prolific author and a highly sought-after speaker on the topic of aging. He currently serves as President and Chief Science Officer of the LEV Foundation, a non-profit organization dedicated to extending healthy human lifespan through regenerative medicine, and as a Scientific Advisor of GENORASIS™.

DR. NIKOLAOS PAPAZOGLOU MD

ELIZABETH PARRISH MBA

DR. WILLIAM H. ANDREWS PHD

DR. MICHAEL KOZLOWSKI OD,PHD

DR. AUBREY DE GREY PHD